Difference between revisions of "Patent Trolls (Blog Post)"
DylanDickens (talk | contribs) (Created page with "{{McNair Projects |Project Title=Patent Trolls (Blog Post) |Topic Area=Patents and Innovation |Owner=Dylan Dickens |Start Term=Summer 2016 |End Term=Summer 2016 |Status=In Wri...") |
(No difference)
|
Revision as of 18:14, 13 June 2016
Patent Trolls (Blog Post) | |
---|---|
Project Information | |
Project Title | |
Start Date | |
Deadline | |
Primary Billing | |
Notes | |
Has project status | |
Copyright © 2016 edegan.com. All Rights Reserved. |
Abstract
A Blog Post on what patent trolls are and some potential ways to combat them.
Blog Post
From the bridges of our favorite storybooks to the deepest parts of internet forums, trolls seem to persistently haunt mankind. Thanks to a practice disproportionately located in the Eastern district of Texas they now haunt our courtrooms. Patent trolls, sometimes misdefined more professionally as non-practicing entities (NPEs) or patent assertion entities (PAEs), don't wield clubs like their fantasy namesakes but are every part as dangerous and troublesome. As reported by Wired, 95% of patents are never used commercially and are rather held by NPEs. Most non-practicing entities, universities being a good example, file patents off of in-house innovations with no intent to commercialize or derive profit.
This is in contrast to patent assertion entities, which generate a majority of their revenue through licensing the patents they own. For example, a large firm may buy up a thousand patents. Instead of creating products derived from those patents, they license these patents to other firms that wish to create those products. With most NPEs and PAEs, if another entity infringes on a patent, the NPE or PAE would in good faith send a demand letter to the infringing entity with a warning. This demand letter warns the infringing entity that they are subject to a lawsuit if they do not acquire the proper licensing of the patent.
Patent trolls push this to the extreme.
References
In line. See above.